Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR (Q28205980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M Samochocki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Zerlin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Jostock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P J Groot Kormelink

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W H Luyten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E X Albuquerque

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Maelicke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

Acta neurologica Scandinavica. Supplementum

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

68-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11261808%20AND%20SRC:MED&resulttype=core&format=json

Cholinergic underactivity in human memory disorders

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Stable expression in HEK-293 cells of the rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

A second pathway of activation of the Torpedo acetylcholine receptor channel

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Chronic nicotine treatment up-regulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2000.00310.X

7 January 2021

10.1034/J.1600-0404.2000.00310.X

Identifiers

DOI

0 references

1 reference